Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial-Reference-Cited by-同舟云学术

Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial

Published:2013-12 Issue:2 Volume:170 Page:215-220
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Bahit Maria Cecilia,Lopes Renato D.,Wojdyla Daniel M.,Hohnloser Stefan H.,Alexander John H.,Lewis Basil S.,Aylward Philip E.,Verheugt Freek W.A.,Keltai Matyas,Diaz Rafael,Hanna Michael,Granger Christopher B.,Wallentin Lars

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study;Benjamin;Circulation,1998

2. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study;Stewart;Am J Med,2002

3. Epidemiologic features of chronic atrial fibrillation: the Framingham study;Kannel;N Engl J Med,1982

4. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm;Peters;Am J Med,1988

5. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study;Ott;Stroke,1997

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary events in elderly patients with non-valvular atrial fibrillation: a prespecified sub-analysis of the ANAFIE registry;Cardiovascular Intervention and Therapeutics;2024-02-13

2. Therapeutic Opportunities of Apixaban in Patients With Atrial Fibrillation and Reducing the Risk of Cerebrovascular Complications in Chronic Kidney Disease;Bulletin of Science and Practice;2024-01-15

3. Clinical Characteristics, Patterns of Use, and incidence of Adverse Events in Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants in Colombia;Vascular Health and Risk Management;2023-03

4. Meta-análisis: Eficacia y seguridad de apixabán frente a warfarina en pacientes con fibrilación auricular para profilaxis de eventos cardiovasculares adversos;CEDAMAZ;2022-12-29

5. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis;Journal of Interventional Cardiac Electrophysiology;2022-09-09